Clovis Oncology
Founded
Founded
Jan 1, 2009
Sources: ror.org
Trials
Collaborator, Phase 2, Active, not recruiting, 20 people, Nov 10, 2020
Collaborator, Phase 1/2, Active, not recruiting, 13 people, Feb 5, 2020
Collaborator, Phase 1/2, Withdrawn, 0 people, Nov 5, 2019
Phase 1/2, Suspended, 227 people, Aug 1, 2019
Collaborator, Phase 1/2, Status unknown, 34 people, Jun 21, 2019
Collaborator, Phase 2, Completed, 33 people, May 21, 2019
Collaborator, Phase 2, Recruiting, 1,500 people, Apr 2, 2019
Collaborator, Phase 2, Completed, 30 people, Oct 3, 2018
Collaborator, Phase 2, Completed, 186 people, Aug 31, 2018
Collaborator, Phase 1/2, Terminated, 12 people, Jun 28, 2018
Collaborator, Phase 1/2, Terminated, 25 people, Jun 15, 2018
Collaborator, Phase 1, Completed, 25 people, Jun 11, 2018
Collaborator, Phase 2, Completed, 49 people, Mar 26, 2018
Collaborator, Phase 2, Completed, 292 people, Nov 9, 2017
Collaborator, Phase 1, Completed, 22 people, Oct 23, 2017
A Study to Test Combination Treatments in Participants With Advanced Gastric Cancer
Collaborator, Phase 2, Completed, 190 people, Oct 17, 2016
Collaborator, Phase 2, Active, not recruiting, 72 people, Aug 22, 2016
Collaborator, Phase 2, Active, not recruiting, 494 people, Feb 9, 2016
Phase 1/2, Terminated, 3 people, Dec 15, 2015
Phase 1/2, Terminated, 7 people, Oct 20, 2015
Sources: clinicaltrials.gov
Funded papers
Apr 18, 2024
Effects of risk factors for ovarian cancer in women with and without endometriosis
Sep 29, 2022
Feb 25, 2021
Sources: openalex.org, api.crossref.org
Named in competing interests
Fees or honoraria, Jul 27, 2026
Grants or research support, Mar 9, 2026
Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years
Fees or honoraria, Feb 2, 2026
Fees or honoraria, Jan 19, 2026
Fees or honoraria, Dec 8, 2025
Letrozole to prevent breast cancer in postmenopausal women with BRCA1/2 mutations (LIBER study)
Fees or honoraria, Nov 7, 2025
Consulting or advice, Jul 4, 2025
Fees or honoraria, Grants or research support, Nov 20, 2023
Consulting or advice, Sep 30, 2022
Fees or honoraria, May 17, 2022
Fees or honoraria, Feb 25, 2022
Grants or research support, Feb 14, 2022
Fees or honoraria, Grants or research support, Feb 4, 2022
Consulting or advice, Sep 1, 2021
Fees or honoraria, Apr 1, 2021
Consulting or advice, Feb 25, 2021
Pan-cancer analysis of whole genomes
Consulting or advice, Board or leadership role, Feb 5, 2020
Sources: pubmed.ncbi.nlm.nih.gov